This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Franceska Fischer: A Trailblazer in Pharmaceutical Innovations
Introduction: Franceska Fischer, an accomplished inventor based in Frankfurt am Main, Germany, has made significant contributions to the field of pharmaceuticals. With one patent to her name, Franceska has demonstrated her expertise and commitment to advancing healthcare solutions.
Latest Patents: Franceska's notable patent, titled "Crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use," pertains to crystalline hydrates designed to address important medical issues. Specifically, the invention offers a compound suitable for use as an antidiabetic, enhancing the treatment options available for diabetes care. The patent describes compounds with a formula where "n" ranges from 2.1 to 2.5, emphasizing the intricacies of this innovative treatment.
Career Highlights: Franceska is currently employed at Sanofi, a leading global biopharmaceutical company known for its dedication to research and innovation in medical solutions. Her role within such a prestigious organization underscores her position as a valuable contributor to the scientific community, and her work reflects her dedication to improving patient outcomes through innovative inventions.
Collaborations: Throughout her career, Franceska has collaborated with talented colleagues, including David Rigal and Bernd Becker. These partnerships have fostered a collaborative environment that promotes creativity and innovation in their research efforts. Together, they have driven forward-thinking projects that hold promise for the advancement of pharmaceutical sciences.
Conclusion: Franceska Fischer is a remarkable inventor whose work is reshaping the pharmaceutical landscape. Her patent on crystalline heteroaromatic fluoroglycoside hydrates exemplifies her commitment to innovation and improving healthcare. As she continues her journey at Sanofi, her contributions will undoubtedly pave the way for new therapeutic options that benefit patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile